Chronic fatigue syndrome, XMRV and blood safety

Future Microbiology

Volumn 6, Issue 4, 2011, Pages 385-389

  Dodd, Roger Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

blood donors; blood safetyn chronic fatigue syndrome; mouse leukemia virusesn policy development; retrovirus; XMRV

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD DONOR; BLOOD SAFETY; BRAIN DISEASE; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; HUMAN; MEDICAL DECISION MAKING; MYALGIC ENCEPHALOPATHY; PRIORITY JOURNAL; RISK MANAGEMENT; VIRUS IDENTIFICATION; XENOTROPIC MULV RELATED VIRUS;

BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; FATIGUE SYNDROME, CHRONIC; HUMANS; MALE; PREVALENCE; PROSTATIC NEOPLASMS; PUBLIC HEALTH; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 79955574732     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.11.24     Document Type: Article

References (28)

1. Urisman A, Molinaro RJ, Fischer N et al.: Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2(3), E25 (2006).
2. Fischer N, Hellwinkel O, Schulz C et al.: Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J. Clin. Virol. 43(3) 227-283 (2008).
3. Hohn O, Krause H, Barbarotto P et al.: Lack of evidence for xenotropic leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 6, 92 (2009).
4. D'Arcy F, Foley R, Perry A et al.: No evidence of XMRV in Irish prostate cancer patients with the R462Q mutation. European Urology Supplements 7(3), 71 (2008).
5. Schlaberg R, Choe DJ, Brown KR, Harshwardhan MT, Singh IR: XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. PNAS 106(38), 16351-16356 (2009).
6. Arnold RS, Makarova NV, Osunkoya AO et al.: XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 75(4), 55-61 (2010).
7. Aloia AL, Sfanos KS, Isaacs WB et al.: XMRV: A new virus in prostate cancer? Cancer Res. 70(24), 10028-10033 (2010).
8. Danielson BP, Ayala GE, Kimata JT: Detection of xenotropic murine leukemia virus-related virus in normal and tumor issue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J. Infect. Dis. 202(10), 1470-1477 (2010).
9. Lombardi VC, Ruscetti FW, Das Gupta J et al.: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326, 85-89 (2009).
10. Coffin JM, Stoye JP: A new virus for old diseases? Science 326(5952), 530-531 (2009).
11. Erlwein O, Kaye S, McClure MO et al.: Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE 5(1), E8519 (2010).
12. Groom HC, Boucherit VC, Makinson K et al.: Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7, 10 (2010).
13. van Kuppeveld FJ, de Jong AS, Lanke KH et al.: Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 340, C1018 (2010).
14. Switzer W, Jia H, Hohn O et al.: Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 7, 57 (2010).
15. Hong P, Li J, Li Y: Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virology J. 7, 224 (2010).
16. Lo S-C, Pripuzova N, Bingjie L et al.: Detection of MLV-related gag gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc. Natl Acad. Sci. USA 107, 15874-15879 (2010).
17. Kaiser J: No meeting of minds on XMRV's role in chronic fatigue, cancer. Science 329(5998), 1454 (2010).
18. Voisset C, Weiss RA, Griffiths DJ: Human RNA "rumor" viruses: the search for novel human retroviruses in chronic diseases. Microbiol. Mol. Biol. Rev. 72(1), 157-195 (2008).
19. Weiss RA: A cautionary tale of virus and disease. BMC Biol. 8, 124 (2010).
20. Robinson MJ, Erlwein OW, Kaye S et al.: Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 7, 108 (2010).
21. Hué S, Gray ER, Gall A et al.: Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 7, 111 (2010).
22. Oakes B, Tai AK, Cingöz O et al.: Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 7, 109 (2010).
23. Sato E, Furuta RA, Miyazawa T: An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR Kit is amplified using standard primers for XMRV. Retrovirology 7, 110 (2010).
24. Dodd RY: Perspective: emerging infections, transfusion safety and epidemiology. N. Engl. J. Med. 349, 1205-1206 (2003). (Pubitemid 37152029)
25. Stramer SL, Fang CT, Foster GA et al.: West Nile virus among blood donors in the United States, 2003 and 2004. N. Engl. J. Med. 353, 451-459 (2005). (Pubitemid 41127289)
26. Stramer SL, Hollinger FB, Katz LM et al.: Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 49(Suppl. 2) S1-S29 (2009).
27. Foster KR, Vecchia P, Repacholi MH: Risk management. Science and the precautionary principle. Science 288, 979-981 (2000). (Pubitemid 30324222)
28. Busch MP, Young MJ, Samson SM, Mosley JW, Ward JW, Perkins HA: Risk of human immunodeficiency virus (HIV) transmission by blood transfusions prior to the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group. Transfusion 31, 4-11 (1991).